REG - AIM - AIM Notice - 24/06/2024

Faron Pharmaceuticals OyAnnouncement

24/06/2024 09:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240624:nRSX4161Ta&default-theme=true

RNS Number : 4161T  AIM  24 June 2024

NOTICE

 

24/06/2024 - 08:00

 

The London Stock Exchange admits the following securities to trading on AIM:

 

 ACUITY RM GROUP PLC
 15,857,143  ORDINARY SHARES 0.1P EACH, FULLY PAID  (BR0WHY7)(GB00BR0WHY71)

 

 ANGLE PLC
 3,561,121  ORDINARY SHARES OF 10P EACH, FULLY PAID  (3433067)(GB0034330679)

 

 EPWIN GROUP PLC
 189,271  ORDINARY SHARES OF 0.05P EACH FULLY PAID  (BNGY4Y8)(GB00BNGY4Y86)

 

 FARON PHARMACEUTICALS OY
 32,617,367  ORDINARY SHARE OF NO PAR VALUE; FULLY PAID (DI)  (BYMKYR0)(FI4000153309)

 

 FLOWTECH FLUIDPOWER PLC
 400,000  ORDINARY SHARES OF 50P EACH FULLY PAID  (BM4NR74)(GB00BM4NR742)

 

 MOSMAN OIL AND GAS LIMITED
 60,000,000  ORDINARY SHARES OF NO PAR VALUE FULLY PAID (DI)  (BJ365T1)(AU0000XINET1)

 

 PUBLIC POLICY HOLDING COMPANY, INC.
 491,678  COMMON SHARES OF USD0.001 EACH, FULLY PAID (DI)  (BL578B9)(US7444301094)

 

 TISSUE REGENIX GROUP PLC
 821,167  ORDINARY SHARES OF 0.1P EACH, FULLY PAID  (BNTXR10)(GB00BNTXR104)

 

If you have any queries or require further information, please contact Market
Operations on 020 7797 4310.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AMOGCGDLRSDDGSB